International Prospective Validation of the EORTC Core Questionnaire for Patient Satisfaction (EORTC PATSAT-C33) and the Outpatient Module (EORTC OUT-PATSAT7) in Phase IV Studies - Takeaways - MDSpire

International Prospective Validation of the EORTC Core Questionnaire for Patient Satisfaction (EORTC PATSAT-C33) and the Outpatient Module (EORTC OUT-PATSAT7) in Phase IV Studies

  • By

  • Anne Brédart

  • Jean-Luc Kop

  • Omar Shamieh

  • Louis Fox

  • Waleed Alrjoub

  • Thierry Conroy

  • Nazim Serdar Turhal

  • I. Juan Arraras

  • Renée Bultijnck

  • Amélie Harle

  • Mieke Van Hemelrijck

  • Eleonora Pinto

  • Eric J. U. Roth

  • Georgios Ioannidis

  • Anna Costantini

  • Tara Chalk

  • Teresa Young

  • Gudrun Rohde

  • Hiroto Ishiki

  • Yuichiro Kikawa

  • Heike Schmidt

  • Vassilios Vassiliou

  • Stephanie Shayler

  • Frédéric Marchal

  • Anota Amélie

  • Jens Lehmann

  • November 26, 2025

  • 0 min

Share

  • 1

    The EORTC PATSAT-C33 and OUT-PATSAT7 questionnaires assess patient satisfaction with cancer care in both inpatient and outpatient settings.

  • 2

    The study involved patients from 12 countries, ensuring cross-cultural applicability and a balanced demographic representation.

  • 3

    Patient satisfaction is crucial for cancer patients, influencing treatment adherence and overall clinical outcomes.

  • 4

    The validation study followed ethical guidelines and received approval from relevant committees, ensuring participant safety.

  • 5

    The research aims to enhance understanding of patient satisfaction in cancer care, aligning with advancements in treatment delivery.

Original Source(s)

Related Content